JP2025511135A5 - - Google Patents
Info
- Publication number
- JP2025511135A5 JP2025511135A5 JP2024557935A JP2024557935A JP2025511135A5 JP 2025511135 A5 JP2025511135 A5 JP 2025511135A5 JP 2024557935 A JP2024557935 A JP 2024557935A JP 2024557935 A JP2024557935 A JP 2024557935A JP 2025511135 A5 JP2025511135 A5 JP 2025511135A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- bispecific antibody
- sequence shown
- domain
- binding domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263325312P | 2022-03-30 | 2022-03-30 | |
| US202263325317P | 2022-03-30 | 2022-03-30 | |
| US63/325,312 | 2022-03-30 | ||
| US63/325,317 | 2022-03-30 | ||
| PCT/US2023/016963 WO2023192514A1 (en) | 2022-03-30 | 2023-03-30 | Bispecific antibodies comprising an nrp1 binding domain and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511135A JP2025511135A (ja) | 2025-04-15 |
| JP2025511135A5 true JP2025511135A5 (https=) | 2025-11-04 |
Family
ID=86184900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557935A Pending JP2025511135A (ja) | 2022-03-30 | 2023-03-30 | Ｎｒｐ１結合ドメインを含む二重特異性抗体およびその使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240101682A1 (https=) |
| EP (1) | EP4499696A1 (https=) |
| JP (1) | JP2025511135A (https=) |
| KR (1) | KR20240163751A (https=) |
| CN (1) | CN119403831A (https=) |
| AU (1) | AU2023245728A1 (https=) |
| CA (1) | CA3255754A1 (https=) |
| CL (1) | CL2024002899A1 (https=) |
| CO (1) | CO2024014799A2 (https=) |
| CR (1) | CR20240462A (https=) |
| IL (1) | IL315960A (https=) |
| MX (1) | MX2024011978A (https=) |
| WO (1) | WO2023192514A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL318499A (en) * | 2022-07-30 | 2025-03-01 | Pinetree Therapeutics Inc | Compounds for targeted lysosomal degradation and methods of using them |
| AU2023378712A1 (en) * | 2022-11-07 | 2025-05-01 | Pinetree Therapeutics, Inc. | Combination therapy comprising bispecific antibodies comprising an nrp1 binding domain |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA96139C2 (uk) * | 2005-11-08 | 2011-10-10 | Дженентек, Інк. | Антитіло до нейропіліну-1 (nrp1) |
| WO2017171373A2 (ko) * | 2016-03-29 | 2017-10-05 | 아주대학교산학협력단 | Egfr 표적 제제에 대한 저항성을 억제하기 위한 조성물 |
| KR102048474B1 (ko) * | 2016-03-29 | 2019-11-26 | 아주대학교산학협력단 | Egfr 표적 제제에 대한 저항성을 억제하기 위한 조성물 |
| CA3060190A1 (en) * | 2017-04-24 | 2018-11-01 | Ichnos Sciences SA | T cell redirecting bispecific antibodies for the treatment of egfr positive cancers |
| WO2020027224A1 (ja) * | 2018-07-31 | 2020-02-06 | 国立大学法人東京大学 | 新たな結合特異性を抗体に付与する超汎用法 |
| WO2020079280A1 (en) * | 2018-10-19 | 2020-04-23 | Ichnos Sciences SA | T cell redirecting bispecific antibodies for the treatment of squamous cell cancers |
-
2023
- 2023-03-30 CN CN202380044206.1A patent/CN119403831A/zh active Pending
- 2023-03-30 CR CR20240462A patent/CR20240462A/es unknown
- 2023-03-30 CA CA3255754A patent/CA3255754A1/en active Pending
- 2023-03-30 KR KR1020247036173A patent/KR20240163751A/ko active Pending
- 2023-03-30 IL IL315960A patent/IL315960A/en unknown
- 2023-03-30 US US18/128,928 patent/US20240101682A1/en active Pending
- 2023-03-30 EP EP23719560.7A patent/EP4499696A1/en active Pending
- 2023-03-30 WO PCT/US2023/016963 patent/WO2023192514A1/en not_active Ceased
- 2023-03-30 AU AU2023245728A patent/AU2023245728A1/en active Pending
- 2023-03-30 JP JP2024557935A patent/JP2025511135A/ja active Pending
-
2024
- 2024-09-27 MX MX2024011978A patent/MX2024011978A/es unknown
- 2024-09-27 CL CL2024002899A patent/CL2024002899A1/es unknown
- 2024-10-29 CO CONC2024/0014799A patent/CO2024014799A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7854016B2 (ja) | 腫瘍治療薬及びその応用 | |
| JP2025111463A5 (https=) | ||
| CN107849148B (zh) | 三特异性结合蛋白质及使用方法 | |
| TW201026325A (en) | Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment | |
| CN116396386A (zh) | Cd3抗体及其药物用途 | |
| JP2024531409A5 (https=) | ||
| WO2022042719A1 (zh) | 抗vegf-抗pd-l1双特异性抗体、其药物组合物及用途 | |
| JP2021510736A5 (https=) | ||
| WO2023174396A1 (zh) | 一种新型免疫调节剂的开发和应用 | |
| JP7533897B2 (ja) | 融合タンパク質およびその使用 | |
| CN114423790B (zh) | 靶向caix抗原的纳米抗体及其应用 | |
| JP2025038088A5 (https=) | ||
| JP2024024114A5 (https=) | ||
| JP2025511135A5 (https=) | ||
| JP2023544143A5 (https=) | ||
| JP2023506834A5 (https=) | ||
| JP2024538148A5 (https=) | ||
| JP2023504733A (ja) | 抗ｃｌｅｃ－１ａ抗体及びその抗原結合性断片 | |
| CN112105391B (zh) | 抗-bcma抗体及其用途 | |
| IL315960A (en) | Bispecific antibodies comprising an nrp1 binding domain and methods of use thereof | |
| WO2023142297A1 (zh) | Muc1结合分子及其应用 | |
| CN114685666B (zh) | 抗间皮素纳米抗体及其应用 | |
| JP2025524306A (ja) | Ｉｔｇａ２を標的とする抗体及びそれを含む抗体薬物複合体 | |
| CN114829405A (zh) | 抗bcma/抗4-1bb双特异性抗体及其用途 | |
| CN110922486A (zh) | 一种分离的结合抗原psma的蛋白及其用途 |